|
?:authorAffiliation
|
-
[\'Department of Sustainable Health Science, Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.\', \'Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan; Graduate School of Public Health, St. Luke\'s International University, Tokyo, Japan; Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.\', \'Department of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Laboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan.\', \'Institute for Business and Finance, Waseda University, Tokyo, Japan.\', \'Department of Mathematical and Computing Science, Tokyo Institute of Technology, Tokyo, Japan.\', \'Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan; Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.\', \'Department of Management Science, Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan; HOXO-M Inc., Tokyo, Japan.\', \'HOXO-M Inc., Tokyo, Japan; Yahoo Japan Corporation, Tokyo, Japan.\', \'Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, USA.\', \'Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.\', \'Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.\', \'Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan. Electronic address: hiroaki.miyata@gmail.com.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}